{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T18:40:10Z","timestamp":1756665610336,"version":"3.44.0"},"reference-count":24,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The foundation for Innovative New Diagnostics","award":["RG212766"],"award-info":[{"award-number":["RG212766"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2024,12,3]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Rapid antigen diagnostic tests (Ag-RDTs) that quickly and accurately identify SARS-CoV-2 are an essential part of the COVID-19 response, but multiple factors can affect the validity of Ag-RDTs results. In Cambodia, several commercial Ag-RDTs have become available since the COVID-19 outbreak, but quality control (QC) and external quality assurance (EQA) of these rapid tests have yet to be fully and systematically implemented. We collaborated with laboratory experts in Australia and piloted an EQA programme of the commonly used COVID-19 Ag-RDTs at the University of Health Sciences\u2019 MERIEUX Laboratory (Tier 1 site\u2014responsible for the in-country receipt and distribution of QA material) and four other participating laboratories (Tier 2\u2014healthcare facility based) between November 2021 and November 2022. The preimplementation training including the Khmer-translated documentation was conducted virtually for Tier 1 laboratories and in-person for Tier 2 laboratories. All QC (n=290) and EQA (n=60) specimens were distributed to the laboratories and testing was performed according to the frequency of Ag-RDTs use in each laboratory. All National Reference Laboratory-provided EQA and QC specimens were tested and results were submitted via the EDCNet portal using QR code scanning. The Tier 1 laboratory reported 100% concordance with the EQA reference result, while some of Tier 2 laboratories\u2019 results were discordant. While continued capacity building and support with troubleshooting have been key to the successful EQA piloting at the UHS laboratory, the programme experienced delays in the shipping\/delivery of EQA and QC panels due to customs and border requirements, which could have hindered implementation and potentially impacted the quality of the QA materials. The pilot EQA programme demonstrated potential scalability and provided data on the reliability of test results at the site. However, to ensure sustainability and practicability of this activity, in-country EQA panel preparation may need to be considered.<\/jats:p>","DOI":"10.1136\/bmjoq-2024-002999","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T20:35:27Z","timestamp":1736195727000},"page":"e002999","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Piloting an external quality assurance program (QAP) for COVID-19 antigen rapid diagnostic tests (Ag-RDTs): findings and lessons learned from Cambodia"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6538-3597","authenticated-orcid":false,"given":"Chan Leakhena","family":"Phoeung","sequence":"first","affiliation":[{"name":"University of Health Sciences, Phnom Penh, Cambodia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Prestedge","sequence":"additional","affiliation":[{"name":"The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Ninan","sequence":"additional","affiliation":[{"name":"The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Cunningham","sequence":"additional","affiliation":[{"name":"The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"St Vincent\u2019s Health Network, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sothavireak","family":"Bory","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Health Sciences, Phnom Penh, Cambodia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennarey","family":"Seang","sequence":"additional","affiliation":[{"name":"Grant Management Office, University of Health Sciences, Phnom Penh, Cambodia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanika","family":"Heng","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Health Sciences, Phnom Penh, Cambodia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Williamson","sequence":"additional","affiliation":[{"name":"The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Markby","sequence":"additional","affiliation":[{"name":"Foundation for Innovative New Diagnostics, Geneva, Gen\u00e8ve, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Valley","sequence":"additional","affiliation":[{"name":"The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kaldor","sequence":"additional","affiliation":[{"name":"The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vonthanak","family":"Saphonn","sequence":"additional","affiliation":[{"name":"Rectorate, University of Health Sciences, Phnom Penh, Cambodia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"2025083111185384000_14.1.e002999.1","doi-asserted-by":"crossref","first-page":"105222","DOI":"10.1016\/j.jcv.2022.105222","article-title":"Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19 pandemic","volume":"154","author":"Donoso Mantke","year":"2022","journal-title":"J Clin Virol"},{"key":"2025083111185384000_14.1.e002999.2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/cclm-2020-0101","article-title":"External quality assessment (EQA) and alternative assessment procedures (AAPs) in molecular diagnostics: findings of an international survey","volume":"59","author":"Payne","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"2025083111185384000_14.1.e002999.3","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.571709","article-title":"An Overview of Nucleic Acid Testing for the Novel Coronavirus SARS-CoV-2","volume":"7","author":"Wang","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2025083111185384000_14.1.e002999.4","doi-asserted-by":"crossref","first-page":"e1253","DOI":"10.1016\/S2214-109X(20)30321-1","article-title":"Leadership training to accelerate progress in public health in sub-Saharan Africa: time for action","volume":"8","author":"Manabe","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2025083111185384000_14.1.e002999.5","doi-asserted-by":"crossref","unstructured":"Manabe YC , Reuland C , Yu T , et al . Variability of salivary and nasal specimens for sars-cov-2 detection. medRxiv [Preprint] 2020. doi:10.1101\/2020.10.07.20208520","DOI":"10.1101\/2020.10.07.20208520"},{"key":"2025083111185384000_14.1.e002999.6","doi-asserted-by":"crossref","unstructured":"Randad PR , Pisanic N , Kruczynski K , et al . COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. medRxiv 2020. doi:10.1101\/2020.05.24.20112300","DOI":"10.1101\/2020.05.24.20112300"},{"key":"2025083111185384000_14.1.e002999.7","article-title":"Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection","volume":"8","author":"Dinnes","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2025083111185384000_14.1.e002999.8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmi.2020.11.004","article-title":"Field evaluation of a rapid antigen test (Panbio COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres","volume":"27","author":"Albert","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2025083111185384000_14.1.e002999.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003735","article-title":"Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis","volume":"18","author":"Br\u00fcmmer","year":"2021","journal-title":"PLoS Med"},{"key":"2025083111185384000_14.1.e002999.10","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0140-6736(21)00673-5","article-title":"The Lancet Commission on diagnostics: transforming access to diagnostics","volume":"398","author":"Fleming","year":"2021","journal-title":"The Lancet"},{"key":"2025083111185384000_14.1.e002999.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00673-5"},{"key":"2025083111185384000_14.1.e002999.12","unstructured":"Use of sars-cov-2 antigen-detection rapid diagnostic tests for covid-19 self-testing. 2022."},{"key":"2025083111185384000_14.1.e002999.13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.47391\/JPMA.3001","article-title":"Assessment of National External Quality Assurance Programme of Pakistan as a tool for improving quality of lab results among participating laboratories","volume":"72","author":"Shah","year":"2022","journal-title":"J Pak Med Assoc"},{"key":"2025083111185384000_14.1.e002999.14","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-021-01505-3","article-title":"Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy","volume":"18","author":"Saeed","year":"2021","journal-title":"Virol J"},{"key":"2025083111185384000_14.1.e002999.15","unstructured":"Interim guidance on the use of rapid antigen tests for covid-19 response. Africa CDC; 2020. Available: https:\/\/africacdc.org\/download\/interim-guidance-on-the-use-of-rapid-antigen-tests-for-covid-19-response"},{"key":"2025083111185384000_14.1.e002999.16","volume-title":"Assessment of the Quality of COVID-19 Antigen Rapid Diagnostic Testing in the Testing Sites of Ekiti State","volume":"14","author":"Kolude","year":"2022"},{"key":"2025083111185384000_14.1.e002999.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222290","article-title":"Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay","volume":"14","author":"Keating","year":"2019","journal-title":"PLoS One"},{"key":"2025083111185384000_14.1.e002999.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104684"},{"key":"2025083111185384000_14.1.e002999.19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbrc.2020.10.069","article-title":"Laboratory testing for the diagnosis of COVID-19","volume":"538","author":"Lai","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"2025083111185384000_14.1.e002999.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104712"},{"key":"2025083111185384000_14.1.e002999.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104654"},{"key":"2025083111185384000_14.1.e002999.22","unstructured":"Laboratory Quality Management System. 1st edn. World Health Organization, 2011. Available: https:\/\/www.who.int\/publications\/i\/item\/9789241548274"},{"key":"2025083111185384000_14.1.e002999.23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.11613\/BM.2017.007","article-title":"Interpretation of EQA results and EQA-based trouble shooting","volume":"27","author":"Kristensen","year":"2017","journal-title":"Biochem Med (Zagreb)"},{"key":"2025083111185384000_14.1.e002999.24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.11613\/BM.2017.013","article-title":"External quality assessment in resource-limited countries","volume":"27","author":"Carter","year":"2017","journal-title":"Biochem Med (Zagreb)"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2024-002999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T18:19:06Z","timestamp":1756664346000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2024-002999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,6]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjoq-2024-002999"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2024-002999","relation":{},"ISSN":["2399-6641"],"issn-type":[{"type":"electronic","value":"2399-6641"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}